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The association between periodontitis and some of the problems with pregnancy such as
premature delivery, low weight at birth, and preeclampsia (PE) has been suggested. Nev-
ertheless, epidemiological data have shown contradictory data, mainly due to differences
in clinical parameters of periodontitis assessment. Furthermore, differences in microbial
composition and immune response between aggressive and chronic periodontitis are not
addressed by these epidemiological studies. We aimed to review the current data on the
association between some of these problems with pregnancy and periodontitis, and the
mechanisms underlying this association. Shifts in the microbial composition of the subgin-
gival biofilm may occur during pregnancy, leading to a potentially more hazardous microbial
community. Pregnancy is characterized by physiological immune tolerance. However, the
infection leads to a shift in maternal immune response to a pathogenic pro-inflammatory
response, with production of inflammatory cytokines and toxic products. In women with
periodontitis, the infected periodontal tissues may act as reservoirs of bacteria and their
products that can disseminate to the fetus-placenta unit. In severe periodontitis patients,
the infection agents and their products are able to activate inflammatory signaling path-
ways locally and in extra-oral sites, including the placenta-fetal unit, which may not only
induce preterm labor but also lead to PE and restrict intrauterine growth. Despite these evi-
dences, the effectiveness of periodontal treatment in preventing gestational complications
was still not established since it may be influenced by several factors such as severity of
disease, composition of microbial community, treatment strategy, and period of treatment
throughout pregnancy. This lack of scientific evidence does not exclude the need to con-
trol infection and inflammation in periodontitis patients during pregnancy, and treatment
protocols should be validated.
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INTRODUCTION
Every year, about 15 million babies around the world are born
preterm (PT) (after 23 weeks and before 37 weeks of gestation).
Over 60% of PT births occur in Africa and South Asia, but PT
birth is truly a global problem. Across 184 countries, the rate of
PT birth ranges from 5 to 18% of the babies born and the highest
rates per live births are presented in Malawi, Comoros, Congo,
Zimbabwe, Equatorial Guinea, Gabon, Pakistan, Indonesia, and
Mauritania (1). In Latin America, PT births comprise 7% of live
births in Chile, 9% in Brazil, and reach 14% in Costa Rica, whereas
in North America, it ranges from 8% in Canada to 12% in the USA.
It is 7% in China. In Europe, it can be as low as 6% in Scandinavian
countries, 7–9% in France, UK, Italy, and Germany, reaching 15%
in Cyprus (2). Spontaneous PT labor leads to 70% of PT births,
whereas the remainder is medically indicated because of maternal
or fetal complications, such as preeclampsia (PE) or intrauterine
growth restriction (3).
Babies born PT and/or those with intrauterine restricted
growth conditions (IUGR) are usually born with low weight
(LBW), which is considered as those born with <2,500 g (4).
Although most studies use this reference value, it is deficient for
PT birth. More recently, other generic references based on birth
weight percentiles adapted to local populations were recently val-
idated (5), but studies on the influence of different parameters
using these new references are still lacking. A survey in 138 low-
income and middle-income countries revealed that 22% of the
children born in 2010 were both term and small-for-gestational-
age, 8.1% were PT and appropriate-for-gestational-age, and 2.1%
were PT and small-for-gestational-age (6).
Preterm birth is the leading cause of newborn deaths (in the
first 4 weeks of life) (1). Low birth weight babies also present a
higher risk of adverse outcomes in the perinatal period, includ-
ing increased mortality rate (7). The mortality risk in the first
month of life is 10–40 times higher for PT-small for the gestational
age than for term and appropriate-for-gestational-age infants (8).
Furthermore, babies born PT are at higher risk of developing neu-
rological, respiratory, and gastrointestinal diseases, attributed to
immaturity of multiple organ systems (3, 9). Many survivors face
a lifetime of disability, including learning disabilities and visual
and hearing problems (1).
Risk factors for small-for-gestational-age babies might differ
from those to reduce the number of babies born PT. In South
Asia, the prevalence of babies born at term but small for the
gestation age is higher than in Latin America. The very high rates
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of small for the gestational age babies might be explained by higher
rates of adolescent pregnancy, chronic maternal malnutrition, low
pre-pregnancy body-mass index, low weight gain in pregnancy,
and low maternal height (8). The prevalence of LBW and PT is
usually higher in low-income populations, however, other factors
besides the socioeconomically status and access to prenatal health
care (10), also influence these rates. Other common causes of PT
birth include genetic and ethnic factors, multiple pregnancies, age,
behavioral, and environmental factors including tobacco usage,
chronic conditions (such as diabetes and high blood pressure),
and infections (1, 11).
One of the most common and dangerous complications of
pregnancy is PE. It is a multisystem disorder associated with ele-
vated blood pressure and proteinuria, typically after 20 weeks of
gestation. PE is primarily a generalized dysfunction of the maternal
endothelium, which appears to be part of an exaggerated systemic
inflammatory response that involves maternal leukocytes and pro-
inflammatory cytokines. Briefly, PE is the result of inadequate
development of maternal spiral arteries due to insufficient tro-
phoblast invasion, leading to narrower blood vessels, which limit
the blood supply from the mother into placental blood spaces.
Acute arthrosis of spiral arteries aggravates the problem, resulting
in hypoxia of the placenta. In a second stage, the ischemic placenta
sheds subcellular trophoblast microparticles to the maternal cir-
culation, which induces maternal leukocytes and endothelial cells
to produce pro-inflammatory cytokines. Worldwide, PE affects an
estimated 2–10% of pregnant women and is the chief cause of
induced PT delivery, and slow growth of infants (12).
Even at very early gestation, fetal cells leak and are found in
maternal circulation. The embryo/fetus expresses paternal anti-
gens, which have to be tolerated throughout the gestation period
by the mother (13). Thus, the maternal immune regulatory system
must be activated in order to suppress maternal immunity toward
fetal antigens, to allow implantation and fetus development during
gestation, but still being able to elicit normal immune responses
against infections (13, 14).
Regular pregnancy is predominantly characterized by a Th2
type immune response, which determines the protective maternal
response to fetal development (15–18). Hormones, such as prog-
esterone and prostaglandin E, play a key role in this Th1–Th2 shift
during pregnancy (14, 19). More recently, the Th1/Th2 paradigm
has been expanded with the addition of Th17 and regulatory T-
cell (Tregs). The Th-17 inflammatory response is also dampened
during pregnancy (20) and Tregs play a key role in maternal tol-
erance. Tregs recruitment and expansion are induced even before
conception by the seminal fluid (21) and then by the embryonic
trophoblasts, and these cells display immunosuppressive features,
promote invasiveness, result in preferential production of Th2
cytokines and reduce the cytotoxicity of decidual natural killer
(NK) cells (22).
Inflammation breaks the homeostasis at the maternal–fetal
interface, revoking these immune privileges during gestation (9)
and induces a Th1 pattern of cytokines, with significant fetal losses
(23). Certain infectious diseases, even sub-clinical infections, may
result in enhanced IL-12 production and in turn an overall shift
toward type 1 bias. Th-1 response leads to the activation of
decidual macrophages, which secrete toxic levels of nitric oxide
and TNF-α. This leads to maternal rejection of the implanted
embryo, which is termed as cytokine-triggered vascular autoam-
putation and involves the activation of coagulation mechanisms,
resulting in vasculitis affecting the maternal blood supply to the
implanted embryo (19). Furthermore, extracellular bacterial or
fungal pathogens elicit a Th17 response, and an imbalance in the
proportion of Th17/Treg is associated with recurrent pregnancy
loss and other gestation adverse effects (13).
Infections during pregnancy, caused by bacteria, viruses, and
parasites, can lead not only to PT birth but also to fetal
death, injury, or other organ sequel depending on the pathogen.
Some pathogens are known as classic teratogens, designated
as TORCH (Toxoplasma gondii, Treponema pallidum, rubella,
cytomegalovirus, and herpes simplex virus), but others may be
included in this list, such as parvovirus B19, varicella zoster virus,
and Plasmodium falciparum (24).
About 50% of the PT births were not associated with any known
factor (11), leading to the search of alternative factors. Maternal
infections of the genitourinary tract may promote the migration
of cervical vaginal bacteria to the uterus (25). Bacteria colonizing
the vagina, such as Escherichia coli, Gardnerella vaginalis, group
B Streptococcus, and Mycoplasma hominis may ascend from the
lower genital tract and were recovered in the amniotic fluid (24)
and placenta (9). Infections in other parts of the body may also
play an important role in the induction of births and prematu-
rity by stimulating an immune response and due to the transit
of microorganisms and/or their toxins in the bloodstream to the
maternal–fetal unit (26).
Thus, differing from the common thinking not too long ago,
the fetal-placenta unit may not be sterile, and nearly one-third of
placental specimens harbor intracellular bacteria in the basal plate
(the tissue layer at and below the maternal–fetal interface). Fur-
thermore, the prevalence of placenta samples with detectable bac-
teria is higher in PT deliveries, although most of these infections
are asymptomatic (27). Also contradicting previous paradigms, a
recent placenta microbiome study reported a very close similarity
between placental and oral microbiomes, and not with the uro-
genital tract microbiome, as expected (28). This latter study has
also revealed a correlation between the placental microbiome with
PT birth.
In this context, the infected periodontal tissues may be asso-
ciated with prematurity by acting as reservoirs of bacteria and
their products, which can disseminate to the fetus-placenta unit.
Furthermore, immunological mediators at high concentrations
produced locally at the infected gingival tissues or systemi-
cally can reach the fetus-placenta unit, resulting in prematu-
rity and low weight at birth (11, 29). Although some aspects
of the association between periodontitis and complications in
pregnancy were elucidated, this relationship needs to be bet-
ter studied and characterized. Therefore, we aimed to review
the existing literature associating periodontal disease, its micro-
biota and immune response with the complications in preg-
nancy.
PREGNANCY AND PERIODONTAL DISEASES
Periodontitis is an inflammatory disease of the soft and hard sup-
port tissues of tooth in response to the supra and subgingival
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microorganisms. It is classically divided into chronic and aggres-
sive periodontitis (30). Chronic periodontitis is characterized by
a slow and continuous destruction of periodontal tissues (31, 32),
while the destruction of the periodontal ligament and alveolar
bone is more rapid and severe in aggressive periodontitis (33).
Furthermore, periodontitis can affect most teeth (generalized), or
can be restricted to a group of teeth, and described as localized.
Despite the enormous microbial diversity in the oral cavity,
up to now, few species were associated with periodontitis (34),
based mainly on their higher prevalence in diseased subjects, and
their elimination after a successful treatment. The Gram negative
anaerobes of the Socransky’s red complex, Porphyromonas gin-
givalis, Treponema denticola, and Tannerella forsythia (35) have
been associated with chronic periodontitis (36). P. gingivalis, T.
denticola, T. forsythia, and the facultative Gram negative rod Aggre-
gatibacter actinomycetemcomitans, particularly serotype b, and to
a lesser extent serotype c, were found in higher levels in patients
with aggressive generalized or localized periodontitis when com-
pared to controls (37, 38). However, patients with localized disease
did not present high IgG titers to T. forsythia as observed for
patients with generalized periodontitis, although both were colo-
nized by the organism, suggesting differences in immune response
associated with the extension of disease (39).
Recent data suggested an additional list of suspected pathogens
formed by 17 species or phylotypes, mostly detected by high
throughput sequencing techniques, but more studies on their
in vivo ecological roles are needed before they can be recognized as
periodontopathogens (40). Despite the dramatic differences in the
microbial composition in healthy periodontium and periodonti-
tis, periodontal pathogens may not directly cause periodontitis but
rather they redesign the typically symbiotic microbiota into a dys-
biotic one, which disrupts the normal homeostatic relationship
with the host tissues (41). Thus, not only would certain pathogens
be involved in the disease but rather a dysbiotic community may
challenge the host, and the inflammatory destructive process is the
result of these multiple interactions.
The response to a microbial challenge is not homogeneous in
man, and several polymorphisms have been reported in genes
associated with the production of cytokines. Some of these poly-
morphisms have been associated with increased susceptibility to
periodontitis in certain populations (42).
The subgingival microbiota and host susceptibility differ
between aggressive and chronic periodontitis, leading to dif-
ferences in cytokines and adhesion molecules (43). The local
cytokines production in gingival tissues differs between types of
periodontitis, although no differences in inflammatory mediators
in serum were demonstrated (44). Gingival tissues from patients
with aggressive periodontitis present higher levels of protein-1-
α (MIP-1α), IFN-γ-induced protein 10 (IP-10) and its receptors
CCR5 and CXCR3, and lower levels of IL-10 than tissues of chronic
periodontitis patients. On the other hand, tissues of chronic peri-
odontitis show increased expression of monocyte chemotactic
protein 1 (MCP-1) and its receptor CCR4 (45).
Likewise, the levels of the adhesion molecule CD11a of T
cells also differ in tissues from aggressive and chronic periodon-
titis, evidencing distinct cellular sources of immune regulatory
cytokines (46). The levels of the pro-inflammatory cytokine IL-17
in gingival crevicular fluid (GCF) of aggressive periodontitis are
higher than in GCF of chronic periodontitis patients, whereas the
levels of IL-11, an anti-inflammatory mediator, were decreased in
aggressive compared to chronic periodontitis (47). Interestingly,
IL-17 induces the production of prostaglandin E2 (PGE2), and is
associated with increased bone loss (48), whereas IL-11 induced
osteoblastic differentiation and bone formation (49).
Not only may periodontitis interfere with pregnancy but also
pregnancy may alter the progression of periodontal diseases
(PD). Physiological changes induced during pregnancy may alter
the inflammatory response, amplifying the gingival inflamma-
tion. Pregnancy gingivitis affects 36–100% of pregnant women
(50). Clinical parameters such bleeding on probing and pocket
depth (PD) may increase during pregnancy, without concomi-
tant increase in plaque index, which decreases after delivery (51).
The mechanisms underlying the increased severity of PD dur-
ing pregnancy were associated to increased vascular permeability,
depression of the immune system, and shifts on the composition
of supra and subgingival microbiota (50).
Early studies have demonstrated that Prevotella intermedia and,
to a lesser extent, P. gingivalis can use progesterone and estradiol
in replacement of vitamin K, a required growth factor for these
species (52). More recently, an increase in salivary progesterone
concentration from the first to the second trimester of pregnancy
has been linked to increased levels of P. gingivalis (50).
Culture and target molecular techniques for bacterial identi-
fication have been used to evaluate the effect of gestation on the
oral microbiota. The increase in clinical parameters of periodontal
disease severity, such as increased bleeding on probing during ges-
tation, is associated with increased levels of anaerobic species asso-
ciated with mature dental biofilm including species of Fusobac-
terium and Prevotella, Streptococcus anginosus, and Streptococcus
intermedius (53). Other data reported that the proportions of
certain putative periodontopathogens such as A. actinomycetem-
comitans and Parvimonas micra were increased during pregnancy
(50). In a case–control study, levels of eight oral bacteria species
(including the red complex and A. actinomycetemcomitans) tended
to increase from 22nd week of pregnancy in mothers of prema-
ture babies, while these levels remained stable in mothers at term
delivery. The prevalence of A. actinomycetemcomitans was very
low in the PT group during early pregnancy, but increased during
pregnancy, reaching levels 2.42-folds higher in the PT group after
delivery than in the term group (54).
The microbial diversity of the oral cavity has still not been eval-
uated in a longitudinal study throughout the gestational period.
However, metagenomic studies on the gut microbiota of pregnant
women may provide some clues on the microbial shifts occurring
in mucosa surfaces over the course of gestation. Metagenomic
analyses of stools of pregnant women in different gestational
phases and controls demonstrated an increase in abundance of
Proteobacteria and Actinobacteria from the first to the third
semester, and a decrease in microbial richness, which persisted
1 month postpartum. Moreover, the microbial shift was followed
by increased levels of IFN-γ, IL-2, IL-6, and TNF-α in stools,
indicating that despite the anti-inflammatory conditions at the
placental interface, gestation leads to low-grade inflammation of
the intestinal mucosa. It is important to notice that the microbial
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composition determined the inflammatory status of the mucosal
surface, and not the opposite, since the experimental transfer of
the fecal microbiota obtained from women at the third semester
of gestation (fecal transplantation) was able to induce inflamma-
tion in recipient mice (55). These data evidenced that changes in
immunity and/or hormone levels during gestation induce changes
in the composition of the microbiota, which leads to increased
inflammatory response in mucosal surfaces.
Altogether, these data provide evidences that physiological
changes associated with pregnancy lead to shifts in the micro-
bial communities colonizing mucosa surfaces, which then induce
pro-inflammatory immune responses. Thus, the already dysbi-
otic microbiota in subgingival sites of PD patients would be
submitted to additional factors promoting imbalance during
pregnancy, increasing its pathogenic potential to induce gingival
inflammation.
Epidemiological data suggested that PD represent a potential
risk for PT birth, as shown in Table 1. Cross-sectional studies
have shown the association between PD and prematurity and/or
low birth weight (56, 57). Case–control studies indicated that peri-
odontitis can increase the risk for prematurity by seven times (58).
On the other hand, two case–control studies carried out in Brazil
(59, 60) showed no relationship between periodontitis and PT low
birth weight.
This review did not aim to cover all epidemiological studies on
the topic but rather to discuss the reasons of conflicting results.
This is covered by several systematic reviews with meta-analyses,
which revealed a significant risk of PT delivery and low birth
weight with periodontitis (69–71). The odds ratio for PT birth in
mothers with periodontitis varied from 1.7 to 2.73; for low birth
weight from 1.5 to 2.11; and for PT birth and low weight, from 2.35
to 3.57. Therefore, all meta-analysis demonstrated that PD could
promote adverse pregnancy outcomes. In addition, meta-analyses
(72, 73) have also identified a significant association between PE
and PD.
As shown in Table 1, the results of some cohort, case–control,
prospective, and cross-sectional studies were conflicting due to
factors as number and demographic characteristics of the par-
ticipants, parameters for periodontal disease diagnosis, inclusion
of pregnant women in different gestation periods, and different
statistical analysis.
Most studies on the association between periodontitis and ges-
tational complications considered the subjects either as diseased
or healthy. However, the incidence of PT delivery increases with
increased severity of periodontitis (74, 75). Furthermore, few stud-
ies correlated the outcome in gestation with microbial parameters
(Table 1). Due to variations in the microbial composition and
immune response among periodontitis patients, it seems clear
that the severity, extension, and type of periodontitis should be
considered when the systemic effects of periodontitis are evalu-
ated in a population. Environmental and genetic factors involved
in altered immune response (42) against bacterial infections may
also influence the effect of periodontitis in pregnancy.
These confounder factors prevented a definitive conclusion
whether periodontitis is an independent risk factor of PT birth
and/or low birth weight or PE, and larger randomized controlled
trials to explore causality and to dissect the biological mechanisms
involved in the association of periodontitis and gestation outcomes
are still needed.
DISSEMINATION OF ORAL BACTERIA AND THEIR PRODUCTS
TO EXTRA-ORAL SITES
The effect of periodontal pathogens in distant sites is related not
only with prematurity and low birth weight babies but also with
other systemic diseases such as arthritis, cardiovascular disease,
atherosclerosis, liver disease, diabetes, stroke (16), and Alzheimer’s
disease (76). Oral bacteria are frequently found infecting extra-
oral sites. S. intermedius was reported causing a brain abscess
(77). A. actinomycetemcomitans is the most prevalent species in
bacterial endocarditis among members of the HACEK group
(Haemophilus, Aggregatibacter, Cardiobacterium, Eikenella, and
Kingella), which includes the facultative anaerobic Gram negative
bacilli that inhabit the oropharynx associated with endocarditis
(78). P. gingivalis (79) and A. actinomycetemcomitans (80) spe-
cific DNA could be detected in atherosclerotic plaques in the
aorta.
Several species present in the gastrointestinal tract and oral cav-
ity were detected in neonatal gastric aspirates (81). The oral origin
of most periodontal pathogens such as A. actinomycetemcomitans,
P. gingivalis, and T. forsythia found in extra-oral sites is highly
possible since they inhabit the oral and no other mucosal surfaces
such as the vagina and intestine. On the other hand, Fusobacterium
nucleatum is associated not only with oral but also with vaginal
mucosa membranes (82, 83). However, the oral origin of F. nuclea-
tum in the placenta-fetal unit has been considered since this species
was detected in samples obtained from neonatal gastric aspirates,
only of mothers with periodontal pockets (83) and the same strain
was not present in the vaginal samples (84).
Analyses of amniotic fluid or placenta samples have demon-
strated the presence of several oral bacteria, mainly P. gingivalis
and F. nucleatum (85–88). P. gingivalis was detected in the amni-
otic fluid from mothers with premature labor and periodontitis.
Subsequently, this periodontal pathogen was detected in placenta,
in chorionic trophoblasts, and in several types of cells such as
amniotic epithelial, decidual, and vascular (87).
Fusobacterium nucleatum is the most frequently detected
species in the amniotic fluid of premature births with intact mem-
branes (89, 90). In addition, F. nucleatum was linked to early-onset
neonatal sepsis once it was detected in cord blood and amniotic
samples from PT births (91–93).
Periodontal pathogens, especially P. gingivalis and A. actino-
mycetemcomitans, were detected in the amniotic fluid of pregnant
women with periodontitis (94). These periodontal pathogens were
also related to placenta infections in hypertensive women (95).
Patients with PE showed higher levels of T. forsythia, F. nuclea-
tum, and A. actinomycetemcomitans in placenta. In addition, 50%
of placenta samples from women with PE were positive for one or
more periodontal pathogens while only 14.3% of the control group
samples had detectable levels of periodontopathogens. Moreover,
infection levels were significantly higher in the PE group (86).
Recently, the placental microbiome was characterized in a
population-based cohort study with placenta samples from 320
subjects (28). Interestingly, a very close similarity between pla-
cental and oral microbiomes was demonstrated, and not with
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Table 1 | Epidemiological data on the association of periodontal diseases and preterm birth and/or low birth weight and other alterations of the
gestational pattern.
Study type Participants number Parameters Results Reference
Case–control Controls n=124
Cases n=93
LBW, MPD, PTB, preterm
labor, premature rupture of
membranes
LBW significantly high in mothers with more
severe PD, indicating that MPD is a significant
risk factor for LBW
Offenbacher et al. (61)
Case–control Controls n=611
Cases n=304
IUGR, LBW, MPD, PTB Results do not support the hypothesis of
association of MPD and IUGR, LBW, and PTB
Bassani et al. (59)
Case–control Control: n=1042
IUGR n=77
LBW n=235
PTB n=238
IUGR, LBW, MPD, PTB MPD is associated with an increased risk for
PTB, LBW, and IUGR
Siqueira et al. (57)
Case–control Controls n=393
LBW n=96
PTB n=110
PTB+LBW n=63
LBW, MPD LBW,
PTB+LBW
MPD was more severe in control individuals
than in cases. The extent of periodontal disease
did not increase risk of LBW. Mean PPD and
frequency of periodontal sites with clinical
attachment level ≥3 mm in PTB+LBW cases
were lower than in control
Vettore et al. (60)
Case–control Controls n=20
PE n=20
MPD, PE PE was associated with MPD. PE cases were
4.33 times more likely to have MPD (OR=4.33)
Varshney and Gautam (62)
Case–control Controls n=44
LBW n=44
Bleeding on probing,
presence of supragingival
calculus and CPITN
(community periodontal
index for treatment
needs), LBW, MPD
MPD was associated with LBW. Mothers of
LBW infants had less healthy areas of gingiva
and more deep pockets
Haerian-Ardakani et al. (63)
Cohort n=1,115 PE, PD Women were at higher risk for preeclampsia if
they had severe periodontal disease at delivery
(OR=2.4), or if they had periodontal disease
progression during pregnancy (OR=2.1)
Boggess et al. (64)
Cross-sectional n=449 LBW, MPD, PTB,
LBW+PTB
There was no statistically significant association
between MPD and LBW
Lunardelli and Peres (56)
Cross-sectional n=277 LBW, MPD, PE, PTB MPD were at higher risk for developing PE,
PTB, and LBW. The rate of PE in women with
PD was 18.6% compared to 7.3% in the control
group (OR=2.7). The OR for PTB was (4.4) and
for LBW was (3.5) when mother had PD
Alchalabi et al. (65)
Cross-sectional n=770 LWB, MPD, PPD, PTB,
reduced maternal
haemomglobin levels
Mothers with PPD >6 mm (OR=2.21) had a
higher risk of LBW. The increase in the severity
of MPD was associated with increased in PTB
and the MPD severity influenced the maternal
hemoglobin levels, i.e., more severe
periodontitis was associated with lower
hemoglobin levels
Kothiwale et al. (66)
Cross-sectional n=390 Periodontopathogens,
MPD
Prevalence of gingivitis was 38% and clinical
periodontitis was 10%. Among the periodontitis
group, high detection rates of P. gingivalis
(56%), Prevotella nigrescens (44%),T. denticola
(32%), and P. intermedia (24%) were associated
with PD
Tellapragada et al. (67)
(Continued)
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Table 1 | Continued
Study type Participants number Parameters Results Reference
Prospective study n=1017 PD, LBW Moderate or severe periodontal disease was
associated with a LBW, a risk ratio of 2.3
(1.1–4.7), adjusted for age, smoking, drugs,
marital and insurance status, and preeclampsia.
Moderate or severe periodontal disease early in
pregnancy is also associated with LBW
Boggess et al. (64)
Prospective study n=283 PD, PE There was a significant relationship between
periodontitis and the occurrence of
preeclampsia among never-smokers (OR=5.56)
Ha et al. (68)
IUGR, intrauterine growth restriction; LBW, low birth weight (<2,500 g); MPD, maternal periodontal disease; PD, periodontal disease; PE, preeclampsia; PPD, probing
pocket depth; PTB, preterm birth (gestacional age <37weeks).
other niches such as the genitourinary tract or the gut. However,
only one patient diagnosed with periodontitis was enrolled in that
study, thus no association between the microbial composition of
placenta and periodontitis could be made.
Present data support the hypothesis that oral bacteria can
reach the maternal–fetal unit and may lead to gestational alter-
ations. However, whether the colonization of commensal or puta-
tive periodontopathogens would result in different outcomes in
pregnancy remains to be elucidated. Further studies, using new
generation sequencing techniques, must be performed to evalu-
ate the diversity of the microbiota at the placenta-fetal unit and
mucosal surfaces, including the oral cavity, in order to establish
the association of specific microbial communities with gestation
alterations.
MECHANISMS INVOLVED IN THE ASSOCIATION BETWEEN
INFECTIONS AND PRETERM BIRTH AND OTHER
GESTATIONAL COMPLICATIONS
The inflammatory cascade triggered by bacterial infections is sup-
posed to play a central role in the pathogenesis associated with
premature birth and fetal injury. Bacterial products stimulate the
production of cytokines by placental tissues, as chorion, decidua,
and trophoblasts (96). During infection, the cytokines produced
by the fetal membranes in response to bacterial pathogens have a
dual role: to control the growth of bacterial agents and, at the same
time, to exacerbate the inflammatory process, which may lead to
fetal injury and premature labor (9).
Generally, there is a relationship between the level of periodon-
tal pathogens colonizing the subgingival sites and the antibody
response to these pathogens (38, 39). However, the data on the
relationship between maternal antibody response to periodontal
pathogens and low weight at birth are contradictory.
Levels of maternal IgG against oral organisms were inversely
related to premature and low weight births, suggesting that the
antibodies would offer protection to the mother and fetus (97).
In contrast, women in the second trimester of pregnancy with
high serum IgG levels to P. gingivalis were more prone to have
low weight babies than those with normal values (98). On the
other hand, pregnant women with periodontitis and low titers
of anti-P. gingivalis antibodies were seven times more at risk of
PT delivery than those with high titers, suggesting that the sup-
pression of maternal IgG response to P. gingivalis would be a risk
factor associated with PT delivery (54). Furthermore, the levels of
antibodies to P. gingivalis were 30% higher in placenta tissue of
PT births due to chorioamnionitis, than in those at term deliv-
ery (87). Overall, the data suggest that high antibodies titers to P.
gingivalis are usually indicative of periodontal pockets with high
levels of this organism, leading to increased risk for PT birth. How-
ever, in heavily colonized women (severe periodontitis), when the
antibodies response to periodontopathogens is low, the risk of
gestation alterations would be higher than in women with high
antibodies titers.
Pathogens and their products are recognized by receptors of
the innate immune system, and the binding of these evolu-
tionarily conserved recognition molecular patterns (PAMPS) to
their receptors activates several signaling pathways, leading to an
inflammatory response aiming to eliminate the bacterial agent.
Each receptor located on the cell surface of various cells of the
human body is specific for the recognition of a PAMP. For instance,
the lipopolysaccharide (LPS), located at the outer membrane of
Gram negative bacteria, is recognized by a toll-like receptor (TLR),
mainly TLR4.
As described in the previous sections, the microbial community
in subgingival sites of periodontitis patients is formed by a high
percentage of Gram negative bacteria, of which the LPS is continu-
ously challenging the host cells. Thus, several studies that reported
the effect of LPS on pregnancy could help explaining the role of the
microbial community on gestational complications. However, it is
worth mentioning that LPS from different bacteria may exhibit
different properties. For instance, P. gingivalis presents a complex
atypical LPS that is not only recognized by TLR4 but also by TLR2,
resulting in different signaling than that promoted by TLR4 bind-
ing (99). On the other hand, P. gingivalis represents a very low
proportion of the subgingival microbiota, despite its association
with periodontitis, and both TLR4 and TLR2 are highly expressed
in inflamed gingival tissues (100). Thus, the effects of E. coli LPS,
a TLR4 binding LPS, as described next, may not be interpreted as
the effects of the whole LPS of subgingival sites.
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Interestingly, the expression of TLR4 in placenta is higher in
women with premature delivery and chorioamnionitis than in
controls (101). LPS induces the production of pro-inflammatory
mediators such as prostaglandins, which are modulators of uter-
ine contractions. In addition, LPS stimulation of uterine tissues
in mice with NK cell deficiency showed a reduction in the pro-
duction of Th1 cytokines. This indicates that the NK cells of the
uterus, which produce cytokines in the early stages of pregnancy,
can be cytotoxic in the presence of pathogens, by producing pro-
inflammatory cytokines such as TNF-α and IL1-β, and leading
to deleterious effects to the fetus such as low placental and fetal
weight (102). It is important to notice that the LPS dose tested
in experimental mice in the latter study was 250 times lower than
used for the endotoxemic shock, thus it would possibly simulate
the LPS produced during a non-lethal infection by a Gram negative
bacteria.
An in vivo model of PE demonstrated that infusions with LPS
in the first and 14th day of gestation induced increased blood pres-
sure and proteinuria (103). Furthermore, the LPS-induced PE led
to disseminated intravascular coagulation (104).
Systemically, periodontitis results in higher levels of several
inflammatory mediators, such as IL-6 and TNF-α, in response
to the challenge promoted by the oral biofilm (105). Experimental
intravenous injection of IL-6 in pregnant rats revealed that this
cytokine can directly induce maternal fetal injury and stimulate
the release of fetal hormones that cause stress (106).
TNF-α is a well-recognized mediator of activation of endothe-
lial injury, a key mechanism of pathogenicity of PE. Blood cells
of patients with severe PE produce higher levels of TNF-α with-
out any stimulus. Nevertheless, LPS stimulus reduced the release
of TNF-α by these cells indicating that the spontaneous release
of TNF-α by leukocytes from patients with PE is the result of the
disease process (107).
However, high concentrations of LPS can modulate
myometrium contraction, and then induce PT delivery, possibly
due to increased levels of IL-6, TNF-α, and PGF2. After treatment
with LPS, additional TNF-α promotes even more contraction of
myometrium cells (108).
Furthermore, an experimental animal model showed that fetal
exposure to LPS can alter the development and permeability of
intestinal epithelium (109), resulting in increased necrotic lesion
(110). The fetal ingestion of amniotic fluid with microorganisms
and microbial products such as LPS can cause enteritis, accelerate
the motility of the colon, and results in the production of meco-
nium during intrauterine life (111). Fetal exposure to intrauterine
infection was also associated with fetal inflammatory response
syndrome, leading to intrauterine growth restriction (112).
Studies in experimental animal models evaluated the effects of
few bacteria species or their products in gestation, and definitively
should not be extrapolated to the effects induced by the whole oral
microbiota. However, they evidenced that the characteristics of the
prenatal infecting pathogen may determine the outcome of infec-
tion in the development of pregnancy. For instance, the challenge
of human fetal membranes with G. vaginalis and Candida albicans,
but not with Streptococcus agalactiae, results in production of IL-
10, which acts essentially in maintaining pregnancy by limiting the
damaging effects of pro-inflammatory cytokines (113).
The intravenous inoculation of different P. gingivalis strains in
rats on the 14th day of gestation, led to the placenta colonization
at the 18th day. Interestingly, placenta colonization was dependent
on the P. gingivalis strain, with a higher virulence potential of the
fimbriated ones (114). Lately, infusion of P. gingivalis LPS on the
14th day of gestation in pregnant rats resulted in increased mater-
nal systolic pressure, reduced placental weight, decreased fetal
weight, and induced fetal resorption without causing generalized
inflammatory response (115).
The intravenous inoculation of F. nucleatum into pregnant
rats resulted in infection of placental membrane and invasion of
the amniotic cavity, causing premature births, stillborn fetus, and
shorter survival (116). Pregnant rats infected with F. nucleatum
showed increased expression of IL-8 in a TLR-dependent manner.
Furthermore, TLR4A (TLR4 agonist), but not TLR2A, reduced
fetal death. Interestingly, TLR4 deficiency led to a reduction in
the inflammatory response without affecting bacterial coloniza-
tion in placenta, suggesting a possible use of TLR4 agonists as
co-adjuvant of antibiotic therapy in the treatment of women with
Gram negative bacterial infections during pregnancy (90).
On the other hand, intravenous inoculation of dental plaque
containing P. gingivalis and F. nucleatum resulted in the presence
of F. nucleatum, but not of P. gingivalis in placenta (88). This data
should be taken with caution since the levels of both species possi-
bly differed in the inoculums, and P. gingivalis exhibits strain with
different virulent potential.
The subcutaneous inoculation of viable or heat-killed (HK)
P. gingivalis in hamsters on the 8th day of gestation resulted
in increased production of PGE2 and TNF-α. In animals inoc-
ulated with HK bacteria, the fetal weight was reduced in 24%
and fetal resorption was 10.6% more frequent than in the con-
trol (117). Moreover, an experimental model in pregnant mice
where viable P. gingivalis cells were inoculated into subcutaneous
cameras resulted in the presence of the bacteria in the uterus and
liver of infected animals, and fetus were small for the gestational
age (118).
Our research group showed that rats infected subcutaneously
with P. gingivalis at different stages of gestation showed elevated
levels of IL-6 and TNF-α in serum and placenta, lower maternal
weight gain, and low fetal weight when compared to non-infected
controls. The infectious process was more intense and widespread
in rats infected before or in the middle of the pregnancy when
compared to groups infected at the beginning of pregnancy. Fetus-
placental resorptions were observed mainly in mid-term pregnant
infected rats, indicating that infection with P. gingivalis interferes
more severely in fetus when the infection occurs at this phase of
pregnancy (119).
Periodontitis induced by ligature in baboons provided evi-
dence of a correlation between anti-P. gingivalis antibodies and
pregnancy alterations (120). Periodontitis induced at the end of
pregnancy resulted in increased production of IL-6, while the levels
of PGE2 and IPB (induction factor of bactericidal permeability)
increased only in groups that received ligature before pregnancy
or in the 3rd month of pregnancy (121).
Despite the value of these results, these trials do not char-
acterize chronic disease observed in humans. In general, these
studies suggest that increased synthesis of inflammatory cytokines
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and metaloproteinases promoted by periodontopathogens could
induce premature labor. Moreover, the translation of data obtained
in animal models to humans may also be jeopardized by dif-
ferences in placenta and uterus structure, hormones regulation,
immune system, length of gestation between other mammals and
humans (122). However, they are valuable evidences of the role
of bacteria and their products in affecting the homeostasis of the
maternal–fetal unit and leading to abnormal pregnancy.
The current understanding of PT labor is that the switch
of the myometrium from a quiescent to a contractile state is
accompanied by a shift in signaling from anti-inflammatory to
pro-inflammatory pathways (3). Microorganisms and their prod-
ucts, including those in subgingival sites, can reach the amniotic
fluid via hematogenous dissemination. They are then recognized
by microbial pattern recognition receptors such as TLRs, signal-
ing the pro-inflammatory pathways in placenta and also in fetal
tissues. Furthermore, the signaling promoted by the periodon-
topathogens in gingival tissues and other sites of infection in the
body contributes to the release of additional inflammatory medi-
ators, which are spread systemically. This shift to an inflammatory
environment not only activates labor but also leads to PE and
restricts intrauterine growth.
EFFECT OF PERIODONTAL TREATMENT ON GESTATIONAL
ALTERATIONS
The effect of periodontal treatment on preventing gestational
alterations is another controversial issue. Given the evidences asso-
ciating periodontitis and gestational complications, various inter-
vention studies were performed in order to determinate the effect
of periodontal treatment on pregnancy outcomes. Studies on the
effect of non-surgical mechanical treatment in pregnant women
with gingival inflammation but limited periodontal destruction
indicated an improvement in clinical parameters and a decrease in
GCF inflammatory markers, but resulted in no significant differ-
ences in gestational outcomes such as PT birth and/or low weight
at birth (123, 124). One exception was a study conducted in Chile,
where the treatment of pregnant women with gingivitis resulted
in a reduction in PT and LBW (125).
Since the link between periodontitis and pregnancy outcomes
seems to be the result of spread of bacteria and their factors to
extra-oral sites, and the consequent inflammatory burden induced
by the pathogens, it seems reasonable that the periodontal treat-
ment would provide better benefits to pregnancy to patients with
severe periodontitis than to those with only gingivitis. This issue
seems especially relevant due to the age of women enrolled in
large randomized populational studies (18–35 years), since severe
periodontitis comprised a very low percentage of participants.
The prevalence of PT births was reduced in women with
severe periodontitis that received periodontal treatment (125–
128). These data contradict other reports, where no positive effects
of periodontal treatment on pregnancy outcomes were observed
(129–132).
Several systematic reviews with meta-analysis on the effect of
maternal periodontal treatment and risk for PT birth and/or low
birth weight did not indicate a decreased risk after treatment (69,
133–135). However, one review suggested a significant effect in
reducing the risk of PT birth for scaling and root planning in
pregnant women with periodontitis for groups with high risk of
PT birth (136).
The conflicting data on the effect of periodontal therapy in pre-
venting PT birth/low birth weight are probably due to differences
in diagnostic criteria of periodontitis, and other conditions com-
mon to both such as smoking, age, and ethnicity. In some studies,
only gingivitis patients were enrolled (125). Furthermore, differ-
ences in disease severity and extension may have accounted for
differences in benefits in gestation outcomes promoted by treat-
ment. For instance, in the study of Offenbacher et al. (126), which
reported the beneficial effects of the periodontal treatment on ges-
tational outcomes, periodontitis patients had at least two sites in
different teeth with PD ≥5 mm and evidence of attachment loss.
On the other hand, in another study where treatment provided no
positive effect for gestation, periodontitis was classified as≥3 mm
of PD in ≥3 teeth (137).
The studies differed also in treatment strategies. After supra
and subgingival mechanical treatment, patients received monthly
periodontal maintenance (129), while in others follow-up was not
mentioned (137). An early study conducted in Chile reported that
the non-surgical periodontal treatment during pregnancy resulted
in a reduction in PT and LBW from 10.11% in the control group
to 1.84% in the test group (138). However, women with severe
periodontitis in the treatment group were submitted to metron-
idazole and amoxicillin administration,which may have controlled
not only the oral microbiota but may also have affected infecting
agents in other sites.
Other differences refer to the control groups. In most studies,
the control group received no periodontal treatment during preg-
nancy (123, 125, 128, 138), which was postponed after the delivery.
One study had no control group for comparison (124), while in
another (137), the control group received supragingival prophy-
laxis, which may have altered inflammation levels and proportions
of pathogens, especially in shallow pockets.
Other limitations of these interventional studies include the
pooling of periodontitis patients with different extension, sever-
ity, and progression rates in a single group. As discussed above,
the microbiota and immune response differ between aggressive
and chronic periodontitis patients, and possibly their effects on
pregnancy outcomes may also differ.
The period of gestation for the periodontal intervention should
also be taken into account when discussing the effect of periodon-
tal treatment in gestational outcomes. One study reported that the
periodontal treatment during the second trimester of pregnancy
led to a reduction of 3.8 times in the risk of PT delivery compared
with the group receiving treatment after birth (128). However,
there are no data comparing the effect of treatment prior or at the
first month of gestation with that performed at later stages, and
most studies reported only that patients were selected before a cer-
tain gestational age, such as 14–20 weeks gestation. The placenta
microbiome study showed that even placenta from periodontally
healthy women may be colonized by oral organisms (28). Animal
model studies indicated that gestational outcomes including low
weight of the fetus are dependent on the period of infection, and an
acute infection immediately before conception or at the middle of
the gestation led to more severe damage to the fetus than infection
at the beginning of gestation (119). Human and animal studies
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reported a microbial shift toward a more pathogenic microbiota
in subgingival sites of periodontitis patients throughout the ges-
tational period. Thus, one could assume that earlier periodontal
treatment during pregnancy (or even before it) would be more
beneficial than the treatment performed at the last trimester of
gestation.
The effect of periodontal treatment on the prevention of PT
delivery and other complications during pregnancy may be influ-
enced by its effect on the bacterial load/composition and on the
host inflammatory response. Infections in the lower genital tract
have been associated with PT labor. Nevertheless, antibiotic treat-
ment of asymptomatic women with bacterial vaginosis has not
reduced the rate of PT delivery (3). Thus, other unknown genetic
factors leading to increased susceptibility to the infection, to an
abnormal response, and/or to PT labor may also play a role.
Gestation is a relatively short physiological process considering
a chronic disease such as periodontitis. It is clear from most studies
that periodontal treatment is able to improve clinical parameters
of periodontitis (42, 123, 124, 131, 136); however, its effects on
gestational outcomes involve several variables, making it hard to
clearly evaluate the effect of periodontal treatment.
Despite the evidences associating PD with gestational out-
comes, the effect of periodontal treatment in pregnancy is still not
supported by scientific evidences. Periodontal treatment protocols
providing the expected benefits for the mother and the fetus are
still needed, and these should be tested in large randomized clin-
ical trials. The periodontal treatment before pregnancy seems an
option, since the severity of periodontitis and the virulence poten-
tial of the microbial community increase during pregnancy and
the deleterious effects of the periodontal infection/inflammation
to the fetus may occur even at very early stages of gestation.
CONCLUSION
Periodontitis are associated with induction of premature births
and other gestational complications, which may compromise the
subject throughout life. Periodontal pathogens may be involved in
this process, directly inducing fetal abnormalities, or inducing the
inflammatory response and the contraction of myocytes, induc-
ing prematurity. However, there are still no data on differences
induced by different oral microbial communities. Furthermore,
the current data had not provided conclusive answers for the effect
of periodontal treatment in preventing PT deliveries and other ges-
tational complications, and definitive intervention protocols were
not established.
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